NOTICIAS
- Could a few bad dietary choices worsen your next immune response?
- How common dietary fats can aggravate chronic itch
- Known for preventing cancer, p53 could also help immune cells fight it
- Immune system protein is a cancer killer on its own, new study shows
- COMPASS pathway enables regulatory T cells to prevent devastating autoimmune responses to gut bacteria
- Specialized immune cells may help skin nimbly respond to changing environmental conditions
- Researchers identify critical window for boosting immunotherapy response in prostate cancer
- Immune changes linked to diabetes could guide development of new cancer treatments
- Mutated immune cells raise red flags in lupus
- Restoring an amino acid can diminish age-related inflammation
- A single sauna session sends immune cells surging through your body
- Preclinical research shows macrophages can be programmed to fight solid cancer tumors
- Needle-free Strep A vaccine triggers local and bodywide immune responses in mice
- Common nutritional supplement may boost psoriasis treatment, small patient trial suggests
- Exploring the potential of immunotherapy in early-stage triple-negative breast cancer
- Mayo Clinic discovers new ways to fight the “zombie” cells that drive aging
PUBLICACIONES
- Could a few bad dietary choices worsen your next immune response?
- Lymphatic pathways in antiviral immunity: from virion transport to host defense
- Vaccine immunity can drive eosinophil recruitment in influenza breakthrough infection with mouse strain-specific outcomes
- How common dietary fats can aggravate chronic itch
- Known for preventing cancer, p53 could also help immune cells fight it
- Immune system protein is a cancer killer on its own, new study shows
- COMPASS pathway enables regulatory T cells to prevent devastating autoimmune responses to gut bacteria
- Promoting tumor antigen presentation unleashes therapeutic efficacy of Tgfbr2-deficient TCR-engineered T cells in pancreatic ductal adenocarcinoma
- Specialized immune cells may help skin nimbly respond to changing environmental conditions
- Th2 cell-mediated ferroptosis as a driver of sebaceous gland dysfunction in atopic dermatitis
- Researchers identify critical window for boosting immunotherapy response in prostate cancer
- Ikaros degradation by Iberdomide correlates with normalization of cytokines in Th cells of patients with systemic lupus erythematosus
- Experimental high blood glucose metabolically rejuvenates CD8+ T cells for improved control of tumor growth through an IGF1-IGF1R axis
- Immune changes linked to diabetes could guide development of new cancer treatments
- Mycoplasma pneumoniae-triggered hemophagocytic lymphohistiocytosis complicated by type I plastic bronchitis in a child: a case report
- N6-methyladenosine epitranscriptomic alterations and their potential implications for maternal–fetal immune tolerance in obstetric antiphospholipid syndrome
- A multi-index diagnostic spectrum for acute myocardial infarction: incorporating the dual axes of inflammation and oxidative stress
- Stem cell factor in allergic diseases: mechanisms of type 2 immunity and therapeutic opportunities
- Correction: Cardiovascular sequelae of Long COVID: immune dysregulation inflammation as central drivers
- Immune cell metabolic reprogramming in pancreatic cancer: roles in tumor progression and therapeutic strategies
- Pseudorabies virus as vaccine vectors for delivering foreign antigens: methodology and application
- Resident mucosal programmes in colon cancer: organ-associated formation and remodelling of the immune niche
- Research progress of the DExD/H-Box RNA helicase family in T cell immune responses
- Longitudinal trajectories of peripheral blood lymphocyte subsets and PD-1 expression as dynamic prognostic markers in lung cancer
- Peripheral neutrophil count and kidney outcomes in IgA nephropathy: a retrospective cohort study of 9,030 patients
- Dihydroartemisinin as a pharmacokinetically constrained immune-conditioning pulse in cancer therapy
- Reported adverse events following monovalent varicella vaccination in children aged 1–12 years: a VAERS disproportionality analysis, 1995-2026
- A progressive ODE model of seasonal allergic rhinitis: from core Th2 axis to 21-dimensional multi- pathway integration with seasonal dynamics and directional assessment
- Tolerogenic dendritic cells attenuate collagen-induced arthritis through a mucosal immunity–gut microbiota–butyrate axis
- Integrating computational and experimental approaches to identify antigen–specific antibodies
- Programmable RNA therapeutics: converging vaccination and on-demand disease treatment via self-adaptive RNA platforms
- Jiangshui-derived Lactobacillus plantarum GR-4 enhances the therapeutic efficacy of PD-1/PD-L1 inhibitors against gastric cancer